BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 19189960)

  • 1. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
    Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
    Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice.
    Liu SL; Li YH; Shi GY; Chen YH; Huang CW; Hong JS; Wu HL
    J Am Coll Cardiol; 2006 Nov; 48(9):1871-9. PubMed ID: 17084265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.
    Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
    Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
    Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
    Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation.
    Anggrahini DW; Emoto N; Nakayama K; Widyantoro B; Adiarto S; Iwasa N; Nonaka H; Rikitake Y; Kisanuki YY; Yanagisawa M; Hirata K
    Cardiovasc Res; 2009 Apr; 82(1):143-51. PubMed ID: 19164391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
    Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
    Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages.
    Shiner M; Fuhrman B; Aviram M
    Free Radic Biol Med; 2004 Dec; 37(12):2052-63. PubMed ID: 15544923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
    Alkemade FE; Gittenberger-de Groot AC; Schiel AE; VanMunsteren JC; Hogers B; van Vliet LS; Poelmann RE; Havekes LM; Willems van Dijk K; DeRuiter MC
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2228-35. PubMed ID: 17656671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation.
    Wei HJ; Li YH; Shi GY; Liu SL; Chang PC; Kuo CH; Wu HL
    Cardiovasc Res; 2011 Nov; 92(2):317-27. PubMed ID: 21840881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
    Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C
    Circulation; 2007 Oct; 116(16):1812-20. PubMed ID: 17893273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
    Yao R; Cheng X; Liao YH; Chen Y; Xie JJ; Yu X; Ding YJ; Tang TT
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):188-95. PubMed ID: 18287887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
    Phillips JW; Barringhaus KG; Sanders JM; Yang Z; Chen M; Hesselbacher S; Czarnik AC; Ley K; Nadler J; Sarembock IJ
    Circulation; 2003 Oct; 108(16):1994-9. PubMed ID: 14517165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.